Cargando…

Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms

BACKGROUND: Both radiotherapy and surgery are now recommended for early stage glottic laryngeal squamous cell carcinoma (LSCC), and both have their own advantages in patients with different characteristics. For each patient, it is hard to determine whether radiotherapy or surgery is more appropriate...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Yajing, Shao, Shali, Lv, Minghe, Zhu, Yi, Yan, Li, Qiao, Tiankui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507900/
https://www.ncbi.nlm.nih.gov/pubmed/33014833
http://dx.doi.org/10.3389/fonc.2020.01669
_version_ 1783585323644616704
author Du, Yajing
Shao, Shali
Lv, Minghe
Zhu, Yi
Yan, Li
Qiao, Tiankui
author_facet Du, Yajing
Shao, Shali
Lv, Minghe
Zhu, Yi
Yan, Li
Qiao, Tiankui
author_sort Du, Yajing
collection PubMed
description BACKGROUND: Both radiotherapy and surgery are now recommended for early stage glottic laryngeal squamous cell carcinoma (LSCC), and both have their own advantages in patients with different characteristics. For each patient, it is hard to determine whether radiotherapy or surgery is more appropriate. METHODS: Patients with T1-2N0M0 glottic LSCC who received radiotherapy or surgery in the 2004–2016 SEER database were reviewed, then randomly divided into training and validation cohorts. Propensity score matching was used to eliminate the baseline variations, and competing risk analyses helped to exclude the effects of other causes of death. Based on univariate and multivariate analyses, we built two nomograms to visually predict the survival of each patient with different characteristics who received radiotherapy or surgery, then validated the accuracy in both training and validation cohorts. Using nomogramEx, we quantified the algorithms of the nomograms and put the nomograms on the websites. RESULTS: A total of 6538 patients in the SEER database were included. We found that therapy (p = 0.004), T stage (p < 0.001), age (p < 0.001), race (p < 0.044), grade (p = 0.001), and marital status (p < 0.001) were independent prognostic factors. Two nomograms were built to calculate the survival for each patient who received radiotherapy (C-index = 0.668 ± 0.050 in the training cohort and 0.578 ± 0.028 in the validation cohort) or underwent surgery (C-index = 0.772 ± 0.045 in the training cohort and 0.658 ± 0.090 in the validation cohort). Calibration plots showed the accuracy of the nomograms. Using the nomograms, we found that 3872 patients (59.22%) had no difference between the two therapies, 706 patients (10.80%) who received radiotherapy had better survival outcomes, and 1960 patients (29.98%) who underwent surgery had better survival outcome. CONCLUSION: Nomograms were used to comprehensively calculate independent factors to determine which treatment (radiotherapy or surgery) is better for each patient. A website was used to offer guidance regarding surgery or radiation for patients and physicians.
format Online
Article
Text
id pubmed-7507900
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75079002020-10-02 Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms Du, Yajing Shao, Shali Lv, Minghe Zhu, Yi Yan, Li Qiao, Tiankui Front Oncol Oncology BACKGROUND: Both radiotherapy and surgery are now recommended for early stage glottic laryngeal squamous cell carcinoma (LSCC), and both have their own advantages in patients with different characteristics. For each patient, it is hard to determine whether radiotherapy or surgery is more appropriate. METHODS: Patients with T1-2N0M0 glottic LSCC who received radiotherapy or surgery in the 2004–2016 SEER database were reviewed, then randomly divided into training and validation cohorts. Propensity score matching was used to eliminate the baseline variations, and competing risk analyses helped to exclude the effects of other causes of death. Based on univariate and multivariate analyses, we built two nomograms to visually predict the survival of each patient with different characteristics who received radiotherapy or surgery, then validated the accuracy in both training and validation cohorts. Using nomogramEx, we quantified the algorithms of the nomograms and put the nomograms on the websites. RESULTS: A total of 6538 patients in the SEER database were included. We found that therapy (p = 0.004), T stage (p < 0.001), age (p < 0.001), race (p < 0.044), grade (p = 0.001), and marital status (p < 0.001) were independent prognostic factors. Two nomograms were built to calculate the survival for each patient who received radiotherapy (C-index = 0.668 ± 0.050 in the training cohort and 0.578 ± 0.028 in the validation cohort) or underwent surgery (C-index = 0.772 ± 0.045 in the training cohort and 0.658 ± 0.090 in the validation cohort). Calibration plots showed the accuracy of the nomograms. Using the nomograms, we found that 3872 patients (59.22%) had no difference between the two therapies, 706 patients (10.80%) who received radiotherapy had better survival outcomes, and 1960 patients (29.98%) who underwent surgery had better survival outcome. CONCLUSION: Nomograms were used to comprehensively calculate independent factors to determine which treatment (radiotherapy or surgery) is better for each patient. A website was used to offer guidance regarding surgery or radiation for patients and physicians. Frontiers Media S.A. 2020-08-26 /pmc/articles/PMC7507900/ /pubmed/33014833 http://dx.doi.org/10.3389/fonc.2020.01669 Text en Copyright © 2020 Du, Shao, Lv, Zhu, Yan and Qiao. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Du, Yajing
Shao, Shali
Lv, Minghe
Zhu, Yi
Yan, Li
Qiao, Tiankui
Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms
title Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms
title_full Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms
title_fullStr Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms
title_full_unstemmed Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms
title_short Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms
title_sort radiotherapy versus surgery–which is better for patients with t1-2n0m0 glottic laryngeal squamous cell carcinoma? individualized survival prediction based on web-based nomograms
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507900/
https://www.ncbi.nlm.nih.gov/pubmed/33014833
http://dx.doi.org/10.3389/fonc.2020.01669
work_keys_str_mv AT duyajing radiotherapyversussurgerywhichisbetterforpatientswitht12n0m0glotticlaryngealsquamouscellcarcinomaindividualizedsurvivalpredictionbasedonwebbasednomograms
AT shaoshali radiotherapyversussurgerywhichisbetterforpatientswitht12n0m0glotticlaryngealsquamouscellcarcinomaindividualizedsurvivalpredictionbasedonwebbasednomograms
AT lvminghe radiotherapyversussurgerywhichisbetterforpatientswitht12n0m0glotticlaryngealsquamouscellcarcinomaindividualizedsurvivalpredictionbasedonwebbasednomograms
AT zhuyi radiotherapyversussurgerywhichisbetterforpatientswitht12n0m0glotticlaryngealsquamouscellcarcinomaindividualizedsurvivalpredictionbasedonwebbasednomograms
AT yanli radiotherapyversussurgerywhichisbetterforpatientswitht12n0m0glotticlaryngealsquamouscellcarcinomaindividualizedsurvivalpredictionbasedonwebbasednomograms
AT qiaotiankui radiotherapyversussurgerywhichisbetterforpatientswitht12n0m0glotticlaryngealsquamouscellcarcinomaindividualizedsurvivalpredictionbasedonwebbasednomograms